Concise update on how AI speeds target identification, lead design, virtual screening and clinical trials, and what this means for precision medicine and pharma R&D.
How AI Is Reshaping Drug Discovery: Speed, Precision, and Risk Reduction Read More »
A concise case study of EMMA, the AI GP receptionist in Rotherham, exploring accent recognition failures, developer responses from QuantumLoopAI, and lessons for inclusive AI in healthcare.
AI Receptionists and Regional Accents: Lessons from Rotherham’s EMMA System Read More »
AI is accelerating drug discovery, gene editing, and synthetic biology faster than rules can adapt. A risk-tiered, adaptive governance model is needed.
AI and Biotechnology: Regulating the Convergence Read More »
A new AI diagnostic platform shows improved early disease detection in clinical trials, speeding diagnosis, cutting false positives, and paving the way for broader clinical use.
AI Advances Early Disease Detection: New Platform Shows Real-World Gains Read More »
FDA clears a combined AI and fundus imaging solution—iHealthScreen’s iPredict-DR with Revenio’s iCare DRSplus—for diabetic retinopathy screening in primary care, widening access to early detection.
Explore how AI boosts healthcare productivity through drug discovery at Pfizer, precision diagnostics at Tempus AI, and surgical robotics and digital hospitals at Stryker.
How AI Is Driving Productivity in Healthcare: Pfizer, Tempus, Stryker Read More »
How AI governance is shaping safe, fair diagnostic AI — market growth, key safeguards, generative AI risks, and the firms building compliant solutions.
AI Governance: Building Trust in Diagnostic Innovation Read More »
How AI is transforming oncology: real-time drug discovery, MRI-guided incision-free ablation, and intraoperative AI imaging that help surgeons identify cancer margins faster and more accurately.
AI Innovations Driving Breakthroughs in Cancer Care Read More »
How AI and tech capital are shifting drug discovery to a fail-fast model, de-risking early R&D while creating investor tensions and strategic tradeoffs.
AI and the ‘Fail-Fast’ Revolution in Drug Discovery Read More »
Explore how AstraZeneca, Haleon, and IXICO apply AI to speed drug discovery, optimize clinical trials, improve neuroimaging, and streamline consumer health operations.
AI’s Practical Applications in Healthcare: Lessons from AstraZeneca, Haleon, and IXICO Read More »
